Biotechnology - Healthcare

Filter

Current filters:

Healthcare

Popular Filters

1 to 25 of 53 results

USA’s 340B Drug Discount Program “needs more oversight,” says BIO

USA’s 340B Drug Discount Program “needs more oversight,” says BIO

01-08-2014

The US Biotechnology Industry Organization’s (BIO) Laurel Todd shared concerns that the 340B program…

BiotechnologyFinancialHealthcareRegulationUSA

Sinovac to provide hepatitis A vaccine in Beijing tender to 2016

Sinovac to provide hepatitis A vaccine in Beijing tender to 2016

21-07-2014

China-based Sinovac Biotech has been selected by the Beijing Health Bureau as the sole supplier of inactivated…

Anti-viralsBiotechnologyChinaHealthcareSinovac BiotechVaccination

The price of NOT curing hepatitis C - by Robert Zirkelbach

The price of NOT curing hepatitis C - by Robert Zirkelbach

20-07-2014

Over the past few months, there has been increased focus on the price of a new cure for hepatitis C,…

Anti-viralsBiotechnologyFinancialHealthcareHepatitis CHepatitis CLiver transplantsMedicineTradeUSA

Celgene’s Imnovid now reimbursed in Sweden, Spain and Switzerland

Celgene’s Imnovid now reimbursed in Sweden, Spain and Switzerland

11-07-2014

US biotech firm Celgene’s Imnovid (pomalidomide), called Pomalyst in the USA, is now approved for reimbursement…

BiotechnologyCelgeneFinancialHealthcareImnovidOncologyPomalystSpainSweden

Northeast England gets $34 million investment to fund biotechnology facility

Northeast England gets $34 million investment to fund biotechnology facility

10-07-2014

The Centre for Process Innovation has announced investment of £20 million ($34 million) to fund a ‘Biologics…

BiotechnologyCentre for Process InnovationCounty DurhamCPIHealthcareNational Biologics Manufacturing CentreUK

ICBA adopts antimicrobial resistance as an inaugural priority, proposed by BIA

ICBA adopts antimicrobial resistance as an inaugural priority, proposed by BIA

27-06-2014

At the inaugural meeting of the newly formed International Council of Biotech Associations (ICBA) which…

Antibiotics and Infectious diseasesBiotechnologyGlobalHealthcareResearch

NHS England agrees funding for Gilead’s hepatitis C drug Sovaldi

18-04-2014

NHS England has approved an £18.7 million ($31.3 million) investment in a new drug for the treatment…

Anti-viralsBiotechnologyFinancialGilead SciencesHealthcareNorthern EuropeSovaldiUK

Pan-European survey calls for a shift in policy for biosimilars

Pan-European survey calls for a shift in policy for biosimilars

19-03-2014

This week, the Alliance for Safe Biologic Medicines (ASBM) disclosed the results of a survey of 470 European…

BiosimilarsBiotechnologyEuropeHealthcareRegulation

Biotie invests in Alzheimer’s drug SYN120 as it drops epilepsy pathway

Biotie invests in Alzheimer’s drug SYN120 as it drops epilepsy pathway

11-03-2014

Finland-based Biotie Therapies (Nasdaq OMX: BTH1V), which is focused on neurodegenerative and psychiatric…

BiotechnologyBiotie TherapiesFinancialFinlandHealthcareNeurologicalNRL-1SYN120

UK government’s Strategy for UK Life Sciences has made progress but must do more, says report

UK government’s Strategy for UK Life Sciences has made progress but must do more, says report

23-01-2014

A review of the UK government's Strategy for UK Life Sciences has found that eight out of the 13 initiatives…

BiotechnologyHealthcarePharmaceuticalPoliticsUK

H1N1 virus market to be worth $273 million by 2018

22-10-2013

The H1N1 vaccines market has been forecast to decline in value over the next five years, reaching a value…

BiotechnologyFinancialGlobalHealthcareVaccines

Leaked Commission research documents raise questions about whose interests are being prioritized

08-10-2013

Scientists, public health researchers and non-governmental organizations have reacted with concern to…

BiotechnologyEuropeHealthcarePharmaceuticalPoliticsResearch

New EULAR recommendations address use of synthetic and biological DMARDs

05-07-2013

The European League Against Rheumatism (EULAR) has this week released updated recommendations for the…

ActemraBiotechnologyBristol-Myers SquibbEuropeHealthcareMabTheraOrenciaPfizerPharmaceuticalRegulationRocheXeljanz

Increased focus on generics and biosimilars only way to make European health care sustainable, says EGA

13-06-2013

Addressing delegates at the 19th European Generic medicines Association (EGA) Annual Conference in Athens,…

BiotechnologyEuropeFinancialGenericsHealthcareRegulation

Government programs play huge role in growth of Turkey's health care market; F&S report

04-06-2013

Government funding, growth and consolidation of the middle class, and the rise in non-communicable diseases…

BiotechnologyEuropeHealthcareMarkets & MarketingPharmaceuticalPolitics

US Senate confirms appointment of Marilyn Tavenner as CMS Administrator

16-05-2013

US Health and Human Services (HHS) Secretary Kathleen Sebelius announced that the US Senate has confirmed…

BiotechnologyGenericsHealthcareManagementNorth AmericaPharmaceutical

MoCA report a welcome stepping stone, but access to orphan medicines remains unfinished business, say trade groups

09-05-2013

The three leading pharma/biotech trade bodies, EuropaBio, the European Federation of Pharmaceutical Industries…

BiotechnologyEuropeHealthcarePharmaceuticalPoliticsRare diseasesRegulation

Progress on better access to medicines for patients in Europe

19-04-2013

Significant progress was made in the work of the Process on Corporate Responsibility in the field of…

BiotechnologyEuropeHealthcarePharmaceuticalPricingRegulation

More research needed on causes of leukemia, as growing lifespan of patients enables study, says GlobalData

18-04-2013

Chronic Myeloid Leukemia (CML) patients are now able to access more successful treatment, which has led…

BiotechnologyEuropeHealthcareNorth AmericaOncologyPharmaceuticalResearch

President Obama's 2014 budget proposal a mixed bag for pharma

11-04-2013

US President Barack Obama $3.77 trillion budget proposal for fiscal 2014 delivers mixed news for the…

BiotechnologyFinancialHealthcareNorth AmericaPharmaceuticalPolitics

UK's NICE to assess value of medicines from 2014

21-03-2013

assessing the full value of medicines when new pricing arrangements are introduced in 2014, the Ministry…

BiotechnologyEuropeHealthcarePharmaceuticalPricing

1 to 25 of 53 results

Back to top